Trial intelligence / Profile preview

Non Invasive Vagal Stimulation for Chemotherapy-induced Nausea in Breast Cancer

NCT04937309Recruiting

Sponsor
University Hospital Tours
Start
Jun 2022
Primary completion
Jul 2028
Countries
1
01

Overview

Randomised trial in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by University Hospital Tours. Primary endpoint: Percentage of patients with significant nausea. Started Jun 2022; status: recruiting.

02

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NCT04937309.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04937309.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call